SPARTA PHARMACEUTICALS INC (CIK: 0000884019) EDGAR, Information, Filings... CompaniesBIO.Com

SPARTA PHARMACEUTICALS INC

Mailing address
PENNSYLVANIA BUSINESS CAMPUS, ROCK PLAZA III 111 ROCK ROAD, HORSHAM, Delaware, 19044-2310
Phone
2154421700
State location
Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

SPARTA PHARMACEUTICALS INC (CIK: 0000884019) is an American company incorporated in the state of Pennsylvania. Head office is located at PENNSYLVANIA BUSINESS CAMPUS, ROCK PLAZA III 111 ROCK RD, HORSHAM, Pennsylvania, 19044-2310. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). SPARTA PHARMACEUTICALS INC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SPARTA PHARMACEUTICALS INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950144-01-000852 ( Act) Size: 9 KB	Jan-10-2001	005-43383 1505251
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000950116-99-001560 ( Act) Size: 4 KB	Aug-13-1999	000-23076 99689326
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950116-99-001553 ( Act) Size: 37 KB	Aug-13-1999	000-23076 99688300
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950116-99-001032 ( Act) Size: 37 KB	May-17-1999	000-23076 99625697
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0000950116-99-000281 ( Act) Size: 274 KB	Feb-23-1999	000-23076 99547632
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001047469-99-003564 ( Act) Size: 8 KB	Feb-05-1999	005-43383 99522649
8-K	Document	Current report filing Acc-no: 0000950116-99-000074 ( Act) Size: 155 KB	Jan-20-1999	000-23076 99508795
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950116-98-002120 ( Act) Size: 53 KB	Oct-30-1998	000-23076 98734174
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000912057-98-000814 ( Act) Size: 32 KB	Oct-13-1998	005-43383 98724539
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000912057-98-000660 ( Act) Size: 31 KB	Sep-10-1998	005-43383 98707555
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950116-98-001672 ( Act) Size: 206 KB	Aug-13-1998	000-23076 98685384
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950116-98-001159 ( Act) Size: 255 KB	May-15-1998	000-23076 98624005
8-K	Document	Current report filing Acc-no: 0000950116-98-001052 ( Act) Size: 11 KB	May-11-1998	000-23076 98615140
8-K	Document	Current report filing Acc-no: 0000950116-98-000945 ( Act) Size: 10 KB	Apr-28-1998	000-23076 98602588
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001047469-98-016235 ( Act) Size: 8 KB	Apr-23-1998	005-43383 98599533
DEF 14A	Document	Definitive proxy statements Acc-no: 0000950116-98-000797 ( Act) Size: 87 KB	Apr-03-1998	000-23076 98586795
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0000950116-98-000643 ( Act) Size: 456 KB	Mar-23-1998	000-23076 98571126
PRE 14A	Document	Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0000950116-98-000618 ( Act) Size: 87 KB	Mar-18-1998	000-23076 98568337
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000912057-98-000559 ( Act) Size: 28 KB	Feb-12-1998	005-43383 98533670
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001047469-97-007975 ( Act) Size: 14 KB	Dec-16-1997	005-43383 97739360

Recent 20 filings. View all SPARTA PHARMACEUTICALS INC filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

SPARTA PHARMACEUTICALS INC overview
SPARTA PHARMACEUTICALS INC job
SPARTA PHARMACEUTICALS INC stock
SPARTA PHARMACEUTICALS INC ownership
SPARTA PHARMACEUTICALS INC CEO
SPARTA PHARMACEUTICALS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.